Skip to main content
Tianshui Zhongxing Bio-technology Co., Ltd. logo

Tianshui Zhongxing Bio-technology Co., Ltd. — Investor Relations & Filings

Ticker · 002772 ISIN · CNE1000020B6 Shenzhen Stock Exchange Agriculture, forestry and fishing
Filings indexed 1,984 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002772

About Tianshui Zhongxing Bio-technology Co., Ltd.

https://www.tszxjy.cn

Tianshui Zhongxing Bio-technology Co., Ltd. specializes in the industrialized cultivation, processing, and distribution of edible fungi. The company utilizes advanced biotechnological methods to operate large-scale factory production facilities. Its primary product portfolio includes enoki mushrooms (Flammulina velutipes), white beech mushrooms, and brown beech mushrooms (Hypsizygus marmoreus). By integrating research and development with modern agricultural practices, the company ensures standardized quality control and high-volume output. Tianshui Zhongxing Bio-technology serves diverse markets, focusing on the supply of fresh and processed mushroom products to retail and food service sectors. The enterprise emphasizes the application of automated climate-controlled environments to optimize growth cycles and maintain product consistency across its supply chain.

Recent filings

Filing Released Lang Actions
第五届董事会第二十五次会议决议公告
Regulatory Filings Classification · 85% confidence The document is a Chinese-listed issuer’s public announcement of resolutions passed at the 25th meeting of its fifth Board of Directors. It lists voting outcomes on investment projects, establishment of a wholly-owned subsidiary, and the adjustment of a stock option exercise price. There is no indication of a management or board member change (appointments, resignations), no shareholder vote, and no financial statements/data as with an interim report. Hence this falls under General Regulatory Filings (RNS) as a board resolution announcement not covered by a more specific category.
2026-05-21 Chinese
关于调整2025年股票期权激励计划行权价格的公告
Regulatory Filings Classification · 75% confidence The document is a corporate announcement by a listed company about adjusting the exercise price of its 2025 stock option incentive plan following the implementation of a dividend scheme. It is a regulatory disclosure regarding a share-based compensation mechanism rather than a full financial report, management report, or financing transaction. It does not fit categories like Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or specific M&A/financing categories. It is best classified as a general regulatory announcement (RNS).
2026-05-21 Chinese
关于对外投资设立全资子公司的公告
Regulatory Filings Classification · 70% confidence The document is a regulatory announcement disclosed on the Shenzhen Stock Exchange by 天水众兴菌业科技股份有限公司 regarding the board-approved external investment to establish a wholly owned subsidiary. It includes risk factors, board resolutions, project details, and impact analysis but contains no financial statements, no fundraising or debt issuance, no voting results, no dividends, and no management changes. It does not fit any of the highly specific categories (e.g., earnings release, capital raise, interim report, M&A filing, share issue) and is therefore best classified under Regulatory Filings (RNS) as a general disclosure.
2026-05-21 Chinese
关于签署项目投资协议的公告
Regulatory Filings Classification · 85% confidence The document is a formal exchange filing announcing and detailing a new project investment agreement (establishing a subsidiary, committing capital, leasing assets, and outlining contractual terms). It is not an earnings release, financial report, or fundraising/financing instrument issue, nor a merger or acquisition of an existing business. It instead falls under miscellaneous regulatory disclosures of material contracts/investment agreements that do not fit other specific categories. Therefore, it is best classified as a general Regulatory Filing (RNS).
2026-05-21 Chinese
2025年度分红派息实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an official announcement by a Chinese listed company detailing its annual profit distribution (dividends) for fiscal 2025: it specifies the dividend amount per 10 shares, total cash dividend, record date, ex-dividend date, payment method, and related parameters. This matches the description of a Notice of Dividend Amount (Code: DIV).
2026-05-11 Chinese
关于使用部分闲置自有资金进行委托理财的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using idle funds for entrusted financial management products. It details amounts redeemed, newly subscribed products, investment terms, and related board approvals. The document is a regulatory announcement about financing activities, specifically about entrusted financial management, but it does not contain financial statements or detailed financial results. It is not a full financial report, earnings release, or management discussion. It is an update on capital usage and financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about financing activities, not just a brief notice or certification, so it is not RPA or RNS.
2026-05-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.